Werbung
Werbung
IMMX
Immix Biopharma, Inc. Common Stock
4.87
USDGesponsert
-0.22
-4.38%
09. Jan., 15:59 UTC -5
Geschlossen
Nach-Markt
4.87
0.00
+0.06%
IMMX Ergebnisberichte
Positives Überraschungsverhältnis
IMMX übertreffen die 5 der letzten 11Schätzungen.
45%
Nächster Bericht
Datum des nächsten Berichts
23. März 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.16
Implizierte Änderung von Q3 25 (Revenue/ EPS)
--
/-33.33%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
--
/--
Immix Biopharma, Inc. Common Stock earnings per share and revenue
On 07. Nov. 2025, IMMX reported earnings of -0.24 USD per share (EPS) for Q3 25, missing the estimate of -0.19 USD, resulting in a -23.84% surprise. Revenue reached --, compared to an expected --, with a --% difference. The market reacted with a +2.86% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analysts forecast an EPS of -0.16 USD, with revenue projected to reach -- USD, implying an decrease of -33.33% EPS, and -- of --% in Revenue from the last quarter.
FAQ
What were Immix Biopharma, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Immix Biopharma, Inc. Common Stock reported EPS of -$0.24, missing estimates by -23.84%, and revenue of --, -- -- expectations.
How did the market react to Immix Biopharma, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 2.86%, changed from $3.15 before the earnings release to $3.24 the day after.
When is Immix Biopharma, Inc. Common Stock expected to report next?
The next earning report is scheduled for 23. März 2026.
What are the forecasts for Immix Biopharma, Inc. Common Stock's next earnings report?
Based on 3
analysts, Immix Biopharma, Inc. Common Stock is expected to report EPS of -$0.16 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung